Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsCreative Biolabs provides an effector function improvement service that provides precise antibody engineering solutions to amplify their natural immune-stimulating capabilities. By meticulously tailoring the antibody's framework, we empower you to develop more potent and effective therapies, accelerating your journey from discovery to impactful treatments. Let us help you engineer antibodies with enhanced effector functions for superior clinical outcomes.
While antibody therapies have transformed healthcare, their optimal impact frequently relies on their capacity to robustly activate the immune system's effector pathways. These effector functions, including ADCC, ADCP, and CDC, play a vital role in eliminating targeted cells. Growing evidence underscores that enhancing these mechanisms can dramatically improve treatment efficacy, especially in cancer therapy. Therefore, fully leveraging the therapeutic capabilities of antibodies necessitates a focus on amplifying their effector functions.
Fig.1 Fc-effector functions enhancement through Fc engineering.1
Creative Biolabs' effector function improvement service provides tailored solutions to optimize antibody effector functions. We offer a comprehensive approach, from initial consultation to final deliverables, ensuring a seamless and efficient process. Our tailored solutions are designed not just to meet your needs, but to anticipate potential obstacles and address them proactively. Specifically, our antibody skeleton engineering strategies involve several aspects, including but not limited to:
Our amino acid substitution service involves replacing one or more amino acid residues within the antibody sequence with different amino acids, such as E333 and K326 in human IgG. These substitutions can significantly impact the antibody's biological activity.
This service is designed to enhance the druggability and therapeutic potency of monoclonal antibodies by combining the strengths of different isotypes, such as IgG and IgA isotypes. By engineering 'cross-isotype' antibodies, Creative Biolabs helps clients achieve higher affinity or binding selectivity for FcγR, leading to improved target cell killing through ADCC, CDC, and ADCP.
Unlock the full therapeutic potential of your biologics through our comprehensive Fc Engineering platform. By leveraging advanced Fc Engineering strategies, we offer precise modulation of antibody effector functions, pharmacokinetics, and biophysical properties to ensure optimal clinical efficacy and safety.
Maximize the anti-tumor potency of your therapeutic antibodies. This service utilizes specific amino acid substitutions or glycoengineering to increase the binding affinity of the Fc region to Fcγ RIIIa (CD16a) on Natural Killer (NK) cells, significantly boosting Antibody-Dependent Cellular Cytotoxicity (ADCC) against low-antigen-expressing targets.
Learn More →Designed for neutralizing antibodies and antagonists where immune cell activation is undesirable. We provide "Effectorless" Fc scaffolds that eliminate binding to Fcγ receptors. This service prevents non-specific cell depletion and cytokine release syndrome (CRS), ensuring a safer therapeutic profile for your candidates.
Learn More →Go beyond cytotoxicity to unlock the full potential of the innate immune system. We engineer the Fc domain to enhance Antibody-Dependent Cellular Phagocytosis (ADCP) by increasing Fcγ RIIa (CD32a) recruitment. This service is ideal for driving macrophage-mediated clearance of pathogens or malignant cells in the tumor microenvironment.
Learn More →Tailored for the treatment of autoimmune diseases and chronic inflammation. By engineering the Fc region to selectively bind the inhibitory receptor Fcγ RIIb, we can downregulate B-cell activation and suppress inflammatory signaling, providing a strategic advantage in developing next-generation anti-inflammatory biologics.
Learn More →Harness the power of the complement system for direct lysis of target cells. Our engineering platform optimizes the interaction between the Fc hexamer and the C1q complex. This service augments Complement-Dependent Cytotoxicity (CDC), offering a potent mechanism of action for targeting resistant bacterial strains or hematological malignancies.
Learn More →Optimize the pharmacokinetics (PK) of your antibody through pH-dependent FcRn engineering. Whether you require extended half-life for reduced dosing frequency or accelerated clearance for diagnostic imaging, we provide precise control over the antibody's persistence in circulation.
Learn More →Ensure your candidate is "manufacturable" and stable. This service focuses on the biophysical aspects of the Fc domain, including improving thermal stability, reducing aggregation propensity, and optimizing solubility. We balance effector modulation with superior developability to streamline your transition from bench to clinic.
Learn More →To thoroughly assess the impact of our engineering, the modified antibody variants are subjected to a detailed battery of in vitro functional assays, specifically designed to rigorously evaluate their effector functions. Beyond our engineering services, we also provide specialized testing capabilities to comprehensively analyze your engineered antibodies:
| Measuring the ability of the variants to mediate target cell killing by effector cells (e.g., NK cells). | |
| Assessing the enhancement in phagocytosis of target cells by macrophages. | |
| Evaluating the ability of the variants to trigger complement-mediated lysis of target cells. | |
| Quantifying the binding affinity of the variants to various Fc receptors (e.g., FcγRIIIa, FcγRIIa, FcγRIIIb, FcγRIIb, FcγRI, FcRn). | |
| Measuring the binding affinity to the complement component C1q. |
Creative Biolabs stands at the forefront of antibody engineering, specializing in enhancing effector functions through sophisticated antibody skeleton engineering. Our proven track record is built upon delivering tailored solutions, leveraging advanced technologies, and harnessing the knowledge of our experienced team. We offer a full spectrum of services, supported by published data, all aimed at accelerating your research and maximizing the success of your antibody therapeutics development. Contact us today to explore how our expertise in antibody skeleton engineering can drive your project forward.
Reference
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
